ニュース
The first systematic whole genome sequencing study of how chemotherapy damages healthy tissues has shown that many, but not ...
All kinds of substances circulate through the bloodstream. Some are beneficial, like oxygen or nutrients, and others less so, ...
A recent study published in the Journal for Immunotherapy of Cancer has revealed a promising new approach for the treatment ...
The oxidase, cytochrome c, assembly 1-like (OXA1L) gene plays a key role in inserting and assembling proteins in the inner ...
Jiangsu Vcare Pharmatech Co. Ltd. has disclosed proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase-binding moiety covalently linked to estrogen receptor (ER) ...
Field Medical Inc. continues to harvest funding from investors for its pulsed field ablation (PFA) system with a $35 million oversubscribed series B financing round. With treatment of atrial ...
The U.K. government revealed its much anticipated 10-year plan to get the National Health Service back on its feet and fit for the future. It is betting on five technologies – data, AI, Genomics, ...
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the bill also restores research and ...
Four days ahead of its July 7 PDUFA date, the U.S. FDA granted accelerated approval to Dizal (Jiangsu) Pharmaceutical Co. Ltd.’s sunvozertinib (DZD-9008), branded as Zegfrovy, for treating adults with ...
The U.S. Health and Human Services and the Justice Departments are bringing more resources to their crack down on False ...
Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the tumor site, enabling them to target ...
Agonists of immune checkpoint modulators for treating autoimmune and inflammatory disorders have shown high potential in ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する